Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension

Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease

NCT01319045 ·Status: TERMINATED ·Phase: NA

Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost

NCT00216931 ·Status: WITHDRAWN ·Phase: NA

The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting

NCT00467896 ·Status: TERMINATED ·Phase: PHASE2

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

NCT01437878 ·Status: TERMINATED ·Phase: PHASE2

Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension

NCT00414687 ·Status: COMPLETED ·Phase: PHASE2

Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)

NCT01598441 ·Status: COMPLETED ·Phase: PHASE3

Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study

NCT01469169 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension

NCT03293407 ·Status: COMPLETED

Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years

NCT00250640 ·Status: COMPLETED

Ventavis® Registry Protocol

NCT00902603 ·Status: TERMINATED

Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension

NCT03044314 ·Status: TERMINATED ·Phase: PHASE4

Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects

NCT00741819 ·Status: COMPLETED ·Phase: PHASE4

Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart Disease

NCT01320878 ·Status: COMPLETED ·Phase: PHASE2

Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)

NCT00882947 ·Status: COMPLETED

Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation

NCT01894035 ·Status: COMPLETED

Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction

NCT00458042 ·Status: TERMINATED ·Phase: PHASE4

Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide

NCT02170519 ·Status: TERMINATED ·Phase: PHASE4

Iloprost Power 15 in Pulmonary Arterial Hypertension

NCT00709956 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

NCT02725372 ·Status: TERMINATED ·Phase: PHASE3

Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction at Altitude

NCT00724321 ·Status: WITHDRAWN ·Phase: PHASE1

Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years

NCT02276872 ·Status: COMPLETED ·Phase: PHASE2

Iloprost Power Disc-15 in Pulmonary Arterial Hypertension

NCT00723554 ·Status: TERMINATED ·Phase: PHASE3

Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children

NCT01723371 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years

NCT01389271 ·Status: COMPLETED

Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension

NCT00314548 ·Status: COMPLETED ·Phase: NA